Us Bancorp \De\ Kala Pharmaceuticals, Inc. Transaction History

Us Bancorp \De\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$2.62 - $5.43 $351 - $727	-134 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$5.06 - $8.15 $131 - $211	-26 Reduced 16.25%	134 $1,000
Q4 2020 Feb 04, 2021	SELL	$6.28 - $8.79 $5,664 - $7,928	-902 Reduced 84.93%	160 $1,000
Q3 2020 Nov 10, 2020	BUY	$7.5 - $11.11 $7,005 - $10,376	934 Added 729.69%	1,062 $8,000
Q2 2020 Aug 07, 2020	BUY	$8.33 - $13.79 $1,066 - $1,765	128 New	128 $1,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.82M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.